Fig. 3From: Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trialsIncidences of somnolence and decreased concentration for 5 days after the initiation of chemotherapyBack to article page